Top 4 Stock Picks of Jacob Rothschild’s RIT Capital Partners

3. IQVIA Holdings Inc. (NYSE:IQV)

RIT Capital Partners’ Stake Value: $38,079,000

Percentage of RIT Capital Partners’ 13F Portfolio: 14.85%

Number of Hedge Fund Holders: 66

IQVIA Holdings Inc. (NYSE:IQV) is the largest human data science technology company, working in collaboration with pharmaceutical companies to carry out clinical trials and clinical research. Jacob Rothschild, via RIT Capital Partners, holds a $38 million position in IQVIA Holdings Inc. (NYSE:IQV), which accounts for 14.85% of the firm’s Q3 portfolio of investments. 

At the end of September, 66 hedge funds monitored by Insider Monkey were long IQVIA Holdings Inc. (NYSE:IQV), with a total stake value of $3.75 billion. This is compared to 69 funds holding stakes in the company in Q2, with stakes valued at $3.8 billion. The leading IQVIA Holdings Inc. (NYSE:IQV) stakeholder is Thomas Steyer’s Farallon Capital, with 2.7 million shares worth $647.6 million. 

On October 27, the Q3 EPS for IQVIA Holdings Inc. (NYSE:IQV) totaled $2.17, beating estimates by $0.05. Revenue for the period equaled $3.39 billion, up 21.72% year-over-year, outperforming estimates by $40.36 million. 

Mizuho analyst Ann Hynes on November 18 raised the price target on IQVIA Holdings Inc. (NYSE:IQV) to $290 from $282 and kept a Buy rating on the shares. The analyst stated that the company’s earnings visibility remains high in the near to mid-term.